Evidence map›Paper›PMID 40909274›Full record

ArticleFrontiers in immunology2025

The role of the 3'-UTR of the chemokine receptor CCR2 and hnRNPA0 in regulating mRNA stability and subcellular distribution in human CD4

Yunus Yukselten, Hanan Wishah, Lingyun Wang, Richard E Sutton

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yunus YukseltenDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, United States.
Hanan WishahDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, United States.
Lingyun WangDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, United States.
Richard E SuttonDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: CCR2, a chemokine receptor critical for immune cell migration, inflammation, and HIV infection, is regulated by poorly understood mechanisms. Methods: This study investigated the unusually long CCR2 3'-UTR's role in post-transcriptional regulation. Results: The full-length 3'-UTR significantly inhibited reporter gene expression in primary CD4+ T cells and macrophages, likely mediated by RNA binding proteins (RBPs). HnRNPA0, was shown to bind directly to this region and influence CCR2 levels. When the RBP binding sites were mutagenized or the 3'- UTR removed using CRISPR-Cas9 and gRNAs, CCR2 mRNA and protein levels significantly increased. Cell fractionation experiments confirmed that these changes occurred in both the nucleus and cytoplasm. To directly test mRNA stability, we used a-amanitin and found that removing the 3'-UTR nearly doubled the half-life of CCR2 mRNA. Finally, pseudotyping studies revealed CCR2 functions as an HIV co-receptor at ~10% efficiency compared to CCR5. Discussion: These results show that the CCR2 3'-UTR plays an important role in post-transcriptional regulation and may provide a novel approach to regulating CCR2 activity in inflammatory or infectious diseases.

Indexed as

3' Untranslated RegionsCD4-Positive T-LymphocytesReceptors, CCR2RNA StabilityGene Expression RegulationHumansMacrophagesRNA, Messenger3' Untranslated RegionsCCR2 protein, humanReceptors, CCR2RNA, MessengerCCR2 3’-UTRCRISPR-Cas9 KOhnRNPA0post-transcriptional regulationR5-tropic HIV co-receptorRNA-binding proteins

Identifiers

PMID40909274
PMCPMC12405378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.